Table 2.
Adverse events
| Adverse Events | FDC (n = 90) | LC (n = 90) | P-value | Odds Ratio (95% CI) |
|---|---|---|---|---|
| Any AE, n (%) | 8 (8.9) | 1 (1.1) | 0.034* | 8.68 (1.07–70.4) |
| Serious AEs, n (%) | 0 (0.0) | 0 (0.0) | NA | NA |
| Discontinuations due to AE, n (%) | 0 (0.0) | 0 (0.0) | NA | NA |
| Deaths, n (%) | 0 (0.0) | 0 (0.0) | NA | NA |
| Hypoglycemia, n (%) | 0 (0.0) | 0 (0.0) | NA | NA |
*p-value from Fisher’s Exact Test. † All AEs were mild and resolved without sequelae. The safety population includes all participants who received at least one dose of study medication
AE = adverse event; CI = confidence interval; FDC = fixed-dose combination; LC = loose combination; NA = not applicable